Application of the Margin of Exposure (MOE) calculation to the WHO Study Group on Tobacco Product Regulation (TobReg) list of tobacco smoke toxicants Fiona H Cunningham, Stacy A Fiebelkorn, Clive Meredith British American Tobacco, Group Research and Development, Southampton, SO15 8TL, United Kingdom. Correspondence: [email protected] INTRODUCTION Tobacco smoke contains over 6,000 constituents, some with well-established toxicological properties (1). To date approximately 150 tobacco smoke constituents have been identified as ‘tobacco smoke toxicants’ (2). We have previously described the use of Margin of Exposure (MOE) calculations to prioritise tobacco smoke toxicants for risk reduction research (3) and here we apply this approach to 18 tobacco smoke toxicants identified by the WHO Study Group on Tobacco Product Regulation (TobReg) (4). RESULTS Table 3 shows the range of MOEs generated (where possible) for the 18 TobReg tobacco smoke toxicants: Table 3 – MOEs generated for the TobReg 18 tobacco smoke toxicants Tobacco Smoke Toxicant MOE Range Acetaldehyde 45-347 Acrolein 0.3-1 Benzene 252-3292 Benzo(a)pyrene 16,805-2,400,000 1,3-Butadiene 220-1826 Carbon Monoxide No MOE Formaldehyde 2-89 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) 278-89,544 N-nitrosonornicotine (NNN) 2759-260,000 Acrylonitrile 5-217 2-Aminonaphthalene 1,870,000 4-Aminobiphenyl 21,000,000-36,000,000 Cadmium 6-602 Catechol No MOE Crotonaldehyde No MOE Hydrogen Cyanide No MOE Hydroquinone No MOE Nitrogen Oxides No MOE BACKGROUND In 2008, the WHO Study Group on Tobacco Product Regulation published a list of 18 tobacco smoke toxicants, which were split across two lists; those they recommended for mandatory lowering and those they recommended for mandatory monitoring (Table 1) (4). Table 1 – TobReg 18 Tobacco Smoke Toxicants Toxicants Recommended for Mandatory Lowering Toxicants Recommended for Mandatory Monitoring Acetaldehyde Acrylonitrile Acrolein 2-Aminonaphthalene Benzene 4-Aminobiphenyl Benzo(a)pyrene Cadmium 1,3-Butadiene Catechol Carbon Monoxide Crotonaldehyde Formaldehyde Hydrogen Cyanide 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) Hydroquinone N-Nitrososnornicotine (NNN) Nitrogen Oxides METHODS An MOE is a ratio between a point of departure (POD) and a specific human exposure. A consensus has been reached that a benchmark dose corresponding to a 10% increase in incidence of the effect in animal studies above control values is an appropriate POD (5). The proposed human exposure scenario was generated by dividing the machine smoked yield of 20 3R4F (University of Kentucky reference cigarettes) smoked under Health Canada Intense (HCI) regime (55 ml puff volume, 2 second puff duration, 30 second puff interval) (6) into the average daily volume of air inhaled by a human subject of 20 m3. Toxicants with MOEs >10,000 accompanied by a dialogue are considered to be “low priority for risk management actions” (5). Our approach calculates MOE values from a range of published studies to determine consistency across data sets and enables segregation of toxicants into high and low priority groupings dependent upon their relationship to the critical value of 10,000. In addition to this we have proposed increasing the number of priority bandings to allow for further prioritisation of the toxicants we believe require exposure reduction research focus (Table 2) (3). Table 2 – Proposed Additional Priority Bandings Priority Rating Banding Top Priority 1 to 10 Very High Priority 10 to 100 High Priority 100 to 1000 Medium Priority 1000 to 10,000 Low Priority 10,000 to 1,000,000 Very Low Priority 1,000,000+ It should be noted that it was not possible to generate MOE values for six of the 18 toxicants. This was due to a lack of relevant endpoint data (catechol, crotonaldehyde, hydrogen cyanide, hydroquinone and nitrogen oxides) or we have been unable to clearly identify a relevant endpoint for that toxicant based on available literature (carbon monoxide). There are also four toxicants for which the priority rating is not achievable. In the case of both NNN and NNK the range of MOEs generated split across multiple priorities. This clearly demonstrates the importance of using multiple data sets to ensure confidence in your overall conclusion. For both of these toxicants we suggest that further investigation is carried out to allow for their prioritisation. In the case of 2-aminonaphthalene, a single useable data set was available, with a relatively short exposure time (3 times a week for 8 weeks followed by a recovery period of 16 weeks (8)) and therefore additional data would be recommended to ensure a firm conclusion. In the case of 4-aminobiphenyl, data used was not based on the target tissue of the lung and gave very large MOEs, the relevance of which can be questioned. Based on the MOE assessments the following priorities can be proposed: Table 4 – Proposed Priority Ratings For each of the 18 tobacco smoke toxicants identified by TobReg, a literature search was conducted to identify (where available) lung specific epidemiological and experimental studies which met the criteria for the generation of multiple BMDL10 values using the Benchmark Dose Software (BMDS) available from the US EPA. From these studies a range of MOEs could then be calculated (3). Example For acetaldehyde, one study identified from the literature was by Woutersen et al (7) in which rats were exposed to acetaldehyde via inhalation for 6 hours per day, 5 days a week for up to 28 months. One of the data sets within that study analysed the number of nasal adenocarcinomas present in the male rats. This data set was run through the BMDS producing a BMDL10 of 154 ppm and the graph seen in figure one, which ultimately resulted in an MOE of 45. Figure 1 – BMDS output for nasal adenocarcinoma in rats (7) Toxicant Priority Rating Acrolein Top Priority Acrylonitrile, Cadmium, Formaldehyde Very High Priority Acetaldehyde, 1,3-Butadiene High Priority Benzene Medium Priority Benzo(a)pyrene Low Priority 4-Aminobiphenyl, 2-Aminonaphthalene, NNN, NNK No clear prioritisation Carbon Monoxide, Catechol, Crotonaldehyde, Hydrogen Cyanide, Hydroquinone, Nitrogen oxides No MOEs DISCUSSION The generation of MOE values for individual tobacco smoke toxicants is the first step towards prioritising toxicants. As can be seen from the data presented, there are still a large number of unknowns or uncertainties around suitability and availability of data sets. However, it must be noted that the criteria used for data selection was very strict (3), in particular focussing on inhalation (not a very common route of exposure in experimental systems) and lung related data sets (often not the target organ of concern for other industries). Where no MOEs or clear prioritisations can be made, utilisation of this approach allows us to focus work programmes on these toxicants to further our assessment and ultimately their prioritisation. However, we recognise a criticism of this approach is that it only investigates toxicants as individual species, rather than factoring in any mixture effects. We have previously proposed a method for investigating a cumulative MOE approach for a group of toxicants with similar modes of action (9), but this approach should be extended to other mixtures. CONCLUSION Further work is required to prioritise those toxicants where no MOEs were generated or where MOEs did not clearly segregate. We suggest the use of mode of action (MOA) reviews, combined with in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling to elucidate details regarding exposure and ADME of these toxicants. We believe that an evidence-based risk assessment method to identify and prioritise individual tobacco smoke toxicants, reflecting the range of yields and human characteristics related to exposure is a useful tool. REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. Rodgman A, Perfetti TA. 2013. The chemical components of tobacco and tobacco smoke. 2nd edition. CRC Press. Pp. 2332. Fowles, J. and Dybing, E., 2003. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco Control 12, 424-430. Cunningham, F. H., Fiebelkorn, S., Johnson, M. and Meredith, C., 2011. A novel application of the Margin of Exposure approach: Segregation of tobacco smoke toxicants. Food and Chemical Toxicology Vol 49 (11), 2921-2933. Burns, D. M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., O’Connor, R., Djordevic, M., Dresler, C., Hainaut, P., Jarvis, M., Opperhuizen, A. and Straif, K., 2008. Mandated Lowering of Toxicants in Cigarette Smoke: A Description of the World Health Organization TobReg Proposal. Tobacco Control 17, 132-141. EFSA, 2005. European Food Safety Authority (EFSA) Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic (Request No EFSA-Q-2004-020). Adopted on 18 October 2005. Available at: http://www.efsa.europa.eu/en/efsajournal/doc/282.pdf. Roemer, E., Schramke, H., Weiler, H., Buettner, A., Kausche, S., Weber, S., Berges, A., Stueber, M., Muench, M., Trelles-Sticken, E., Pype, J., Kohlgrueber, K., Voelkel, H. and Wittke, S., 2012. Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F and 2R4F. Beitrage zur Tabakforschung International/Contributions to Tobacco Research 25, 316-335. Woutersen, R.A., Appelman, L.M., van Garderen-Hoetmer, A. and Feron, V.J., 1986. Inhalation toxicity of acetaldehyde in rats III Carcinogenicity study. Toxicology 41, 213-231. Stoner, G. D., Conran, P. B., Greisiger, E. A., Stober, J., Morgan, M. and Pereira, M. A., 1986. Comparison of two routes of chemical administration on the lung adenoma response in strain A/J mice. Toxicology and. Applied Pharmacology 82: 19-31. Cunningham, F. H., Fiebelkorn, S. and Meredith, C., 2012 ‘Cumulative risk assessment of three aldehydes present in tobacco smoke: using margin of exposure (MOE) and mode of action (MOA) evaluations’. The Toxicologist (Supp to Tox Sci) 126 (1), 25. PS 127. www.bat-science.com
© Copyright 2024 ExpyDoc